Skip to main content
Erschienen in: Netherlands Heart Journal 10/2009

01.10.2009 | Original article

Influence of transoesophageal echocardiography on therapy and prognosis in young patients with TIA or ischaemic stroke

verfasst von: T. C. D. Rettig, B. J. Bouma, R. B. A. van den Brink

Erschienen in: Netherlands Heart Journal | Ausgabe 10/2009

Einloggen, um Zugang zu erhalten

Abstract

Objective. To determine the influence of transoesophageal echocardiography (TEE) on therapy and prognosis in patients with cryptogenic transient ischaemic attack (TIA) or ischaemic stroke under the age of 50 years.
Methods and results. We evaluated all patients aged 50 and under who were referred to our university hospital for cryptogenic TIA or ischaemic stroke during the period 1 January 1996 to 31 December 2004. All patients underwent both transthoracic echocardiography (TTE) and TEE. Patients with known pre-existent heart disease, such as atrial fibrillation, were excluded. Eighty-three patients with TIA (22) and ischaemic stroke (61) were enrolled. Mean age was 39±8 years (range 18 to 50). In 30% of the patients TEE detected one or more potential cardioembolic source, compared with 10% for TTE (p=0.003). Standard treatment (aspirin 38 mg daily) was changed in 7% of the patients due to the TEE findings. Complete followup was obtained in 93% with an average of 5±3 years. Twelve recurrences occurred; two out of six patients (33%) with therapy change and ten out of 71 (14%) of the patients without therapy change had a recurrent TIA or ischaemic Stroke.
Conclusion. In patients with cryptogenic TIA or ischaemic stroke, TEE is superior to TTE in the detection of a potential cardiac source of embolism. However, findings obtained by TEE only influence the already initiated treatment in a small percentage of patients. The recurrence rate both in the group with and without therapy change is high. (Neth Heart J 2009;17:373–7.)
Literatur
1.
Zurück zum Zitat Yonemura K, Kimura K, Hasegawa Y, Yokota C, Minematsu K, Yamaguchi T. Analysis of ischemic stroke in patients aged up to 50 years. Rinsho Shinkeigaku. 2000;40:881–6. Yonemura K, Kimura K, Hasegawa Y, Yokota C, Minematsu K, Yamaguchi T. Analysis of ischemic stroke in patients aged up to 50 years. Rinsho Shinkeigaku. 2000;40:881–6.
2.
Zurück zum Zitat Cerrato P, Grasso M, Imperiale D, Priano L, Baima C, Giraudo M, et al. Stroke in young patients: etiopathogenesis and risk factors in different age classes. Cerebrovasc Dis. 2004;18:154–9. Cerrato P, Grasso M, Imperiale D, Priano L, Baima C, Giraudo M, et al. Stroke in young patients: etiopathogenesis and risk factors in different age classes. Cerebrovasc Dis. 2004;18:154–9.
3.
Zurück zum Zitat Asinger RW, Dyken ML, Fisher M, Harrison MJG, Hart RG, Sherman DG. Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force. Arch Neurol. 1989;46:727–43. Asinger RW, Dyken ML, Fisher M, Harrison MJG, Hart RG, Sherman DG. Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force. Arch Neurol. 1989;46:727–43.
4.
Zurück zum Zitat Flemming KD, Brown RD, Pety GW, Huston J 3rd, Kallmes DF, Piepgrad DG. Evaluation and Management of Transient Ischemic Attack. Mayo Clin Proc. 2004;79:1071–86. Flemming KD, Brown RD, Pety GW, Huston J 3rd, Kallmes DF, Piepgrad DG. Evaluation and Management of Transient Ischemic Attack. Mayo Clin Proc. 2004;79:1071–86.
5.
Zurück zum Zitat Harloff A, Handke M, Reinhard M, Geibel A, Hetzel A. Therapeutic Strategies After Examination by Transesophageal Echocardiography in 503 Patients With Ischemic Stroke. Stroke. 2006;37:859–64. Harloff A, Handke M, Reinhard M, Geibel A, Hetzel A. Therapeutic Strategies After Examination by Transesophageal Echocardiography in 503 Patients With Ischemic Stroke. Stroke. 2006;37:859–64.
6.
Zurück zum Zitat Ward RP, Don CW, Furlong KT, Lang RM. Predictors of Long-Term Mortality in Patients With Ischemic Stroke Referred for Transesophageal Echocardiography. Stroke. 2006;37:204–8. Ward RP, Don CW, Furlong KT, Lang RM. Predictors of Long-Term Mortality in Patients With Ischemic Stroke Referred for Transesophageal Echocardiography. Stroke. 2006;37:204–8.
7.
Zurück zum Zitat Kapral MK, Silver FL. Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care. CMAJ. 1999;161:989–96. Kapral MK, Silver FL. Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care. CMAJ. 1999;161:989–96.
8.
Zurück zum Zitat Leung DY, Black IW, Cranney GB, Walsh WF, Grimm RA, Stewart WJ, et al. Selection of patients for transesophageal echocardiography after stroke and systemic embolic events. Role of transthoracic echocardiography. Stroke. 1995;26:1820–4. Leung DY, Black IW, Cranney GB, Walsh WF, Grimm RA, Stewart WJ, et al. Selection of patients for transesophageal echocardiography after stroke and systemic embolic events. Role of transthoracic echocardiography. Stroke. 1995;26:1820–4.
9.
Zurück zum Zitat Warner MF, Momah KI. Routine transesophageal echocardiography for cerebral ischemia. Is it really necessary? Arch Intern Med. 1996;156:1719–23. Warner MF, Momah KI. Routine transesophageal echocardiography for cerebral ischemia. Is it really necessary? Arch Intern Med. 1996;156:1719–23.
10.
Zurück zum Zitat Cujec B, Polasek P, Voll C, Shuaib A. Transesophageal echocardiography in the detection of potential cardiac source of embolism in stroke patients. Stroke. 1991;22:727–33. Cujec B, Polasek P, Voll C, Shuaib A. Transesophageal echocardiography in the detection of potential cardiac source of embolism in stroke patients. Stroke. 1991;22:727–33.
11.
Zurück zum Zitat Rauh R, Fischereder M, Spengel FA. Transesophageal echocardiography in patients with focal cerebral ischemia of unknown cause. Stroke. 1996;27:691–4. Rauh R, Fischereder M, Spengel FA. Transesophageal echocardiography in patients with focal cerebral ischemia of unknown cause. Stroke. 1996;27:691–4.
12.
Zurück zum Zitat Kizer JR, Devereux RB. Patent foramen ovale in young adults with unexplained stroke. N Engl J Med. 2005;353:2361–72. Kizer JR, Devereux RB. Patent foramen ovale in young adults with unexplained stroke. N Engl J Med. 2005;353:2361–72.
13.
Zurück zum Zitat Rabinstein AA, Chirinos JA, Fernandez FR, Zambrano JP. Is TEE useful in patients with small subcortical strokes?. Eur J Neurol. 2006;13:522–7. Rabinstein AA, Chirinos JA, Fernandez FR, Zambrano JP. Is TEE useful in patients with small subcortical strokes?. Eur J Neurol. 2006;13:522–7.
14.
Zurück zum Zitat DeRook FA, Comess KA, Albers GW, Popp RL. Transesophageal echocardiography in the evaluation of stroke. Ann Intern Med. 1992;117:922–32. DeRook FA, Comess KA, Albers GW, Popp RL. Transesophageal echocardiography in the evaluation of stroke. Ann Intern Med. 1992;117:922–32.
15.
Zurück zum Zitat Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol. 2005;58:688–97. Ay H, Furie KL, Singhal A, Smith WS, Sorensen AG, Koroshetz WJ. An evidence-based causative classification system for acute ischemic stroke. Ann Neurol. 2005;58:688–97.
16.
Zurück zum Zitat Blackshear JL, Baker VS, Rubino F, Safford R, Lane G, Flipse T, et al. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet. 1996;348:633–8. Blackshear JL, Baker VS, Rubino F, Safford R, Lane G, Flipse T, et al. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet. 1996;348:633–8.
17.
Zurück zum Zitat Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter Closure versus Medical Therapy of Patent Foramen Ovale and Presumed Paradoxical Thromboemboli. A Systematic Review. Ann Intern Med. 2003;139:753–60. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter Closure versus Medical Therapy of Patent Foramen Ovale and Presumed Paradoxical Thromboemboli. A Systematic Review. Ann Intern Med. 2003;139:753–60.
18.
Zurück zum Zitat Cujec B, Polasek P, Voll C, Shuaib A. Transesophageal echocardiography in the detection of potential cardiac source of embolism in stroke patients. Stroke. 1991;22:727–33. Cujec B, Polasek P, Voll C, Shuaib A. Transesophageal echocardiography in the detection of potential cardiac source of embolism in stroke patients. Stroke. 1991;22:727–33.
19.
Zurück zum Zitat Hata JS, Ayres RW, Biller J, Adam HP Jr, Stuhlmuller JE, Burns TL et al. Impact of transesophageal echocardiography on the anticoagulation management of patients admitted with focal cerebral ischemia. Am J Cardiol. 1993;72:707–10. Hata JS, Ayres RW, Biller J, Adam HP Jr, Stuhlmuller JE, Burns TL et al. Impact of transesophageal echocardiography on the anticoagulation management of patients admitted with focal cerebral ischemia. Am J Cardiol. 1993;72:707–10.
20.
Zurück zum Zitat Marini C, Totaro R, Carolei A. Long-term prognosis of cerebral ischemia in young adults. National Research Council Study Group on Stroke in the Young. Stroke. 1999;30:2320–5. Marini C, Totaro R, Carolei A. Long-term prognosis of cerebral ischemia in young adults. National Research Council Study Group on Stroke in the Young. Stroke. 1999;30:2320–5.
21.
Zurück zum Zitat Varona JF, Bermejo F, Guerra JM, Molina JA. Long-term prognosis of ischemic stroke in young adults. Study of 272 cases. J Neurol. 2004;251:1507–1. Varona JF, Bermejo F, Guerra JM, Molina JA. Long-term prognosis of ischemic stroke in young adults. Study of 272 cases. J Neurol. 2004;251:1507–1.
22.
Zurück zum Zitat Leys D, Bandu L, Henon H, Lucas C, Mounier-Vehier F, Rondepierre P, et al. Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke. Neurology. 2002; 59:26–33. Leys D, Bandu L, Henon H, Lucas C, Mounier-Vehier F, Rondepierre P, et al. Clinical outcome in 287 consecutive young adults (15 to 45 years) with ischemic stroke. Neurology. 2002; 59:26–33.
23.
Zurück zum Zitat Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002;105:2625–31. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002;105:2625–31.
24.
Zurück zum Zitat Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG, Mas JL. Patent foramen ovale: is stroke due to paradoxical embolism? Stroke. 1993;24:31–4. Ranoux D, Cohen A, Cabanes L, Amarenco P, Bousser MG, Mas JL. Patent foramen ovale: is stroke due to paradoxical embolism? Stroke. 1993;24:31–4.
25.
Zurück zum Zitat Nighoghossian N, Perinetti M, Barthelet M, Adeleine P, Trouillas P. Potential cardioembolic sources of stroke in patients less than 60 years of age. Eur Heart J. 1996;17:590–4. Nighoghossian N, Perinetti M, Barthelet M, Adeleine P, Trouillas P. Potential cardioembolic sources of stroke in patients less than 60 years of age. Eur Heart J. 1996;17:590–4.
Metadaten
Titel
Influence of transoesophageal echocardiography on therapy and prognosis in young patients with TIA or ischaemic stroke
verfasst von
T. C. D. Rettig
B. J. Bouma
R. B. A. van den Brink
Publikationsdatum
01.10.2009
Verlag
Bohn Stafleu van Loghum
Erschienen in
Netherlands Heart Journal / Ausgabe 10/2009
Print ISSN: 1568-5888
Elektronische ISSN: 1876-6250
DOI
https://doi.org/10.1007/BF03086287

Weitere Artikel der Ausgabe 10/2009

Netherlands Heart Journal 10/2009 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.